Respiratory News and Research

RSS

Rapid molecular testing transforms treatment for community-acquired pneumonia

Pneumonia is an inflammatory condition affecting the lungs, typically resulting from an infection with viruses or bacteria.

7 Mar 2024

COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals

The potential of COVID-19 booster vaccine products (antibodies) passed from mother to offspring through breastmilk.

7 Mar 2024

Can postbiotics improve athletic performance and recovery?

Researchers describe the utility of postbiotics in improving exercise performance and recovery.

6 Mar 2024

COVID-19 exposes deep-rooted structural inequities affecting vaccine uptake among ACB groups

The influence of poor vaccination uptake among African, Caribbean, and Black (ACB) communities.

6 Mar 2024

CUNY and Pfizer launch new project to track acute respiratory infections across the United States

The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), in collaboration with Pfizer, are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States.

5 Mar 2024

COVID-19 linked to long-lasting cognitive deficits, study finds

Study in England suggests that COVID-19 may lead to long-term cognitive deficits, with more severe impacts observed in individuals infected early in the pandemic or with prolonged symptoms.

4 Mar 2024

How long do cognitive and memory dysfunctions persist after SARS-CoV-2 infection?

Whether cognitive deficits can be measured after severe acute respiratory syndrome (SARS-CoV-2) infection.

4 Mar 2024

Only 9% of older Americans vaccinated against RSV, study finds

A new study from the Texas A&M University School of Public Health found that only 9 percent of older Americans had been vaccinated against respiratory syncytial virus (RSV) prior to this fall and winter, despite the threat of increased rates of hospitalization and deaths nationwide from the virus.

1 Mar 2024

Latest COVID-19 booster halves risk of moderate or severe disease in adults

The most recent COVID-19 booster shot reduces adults' risk of moderate or severe COVID by more than half, according to a new nationwide data study from September 2023 through January 2024, a period of JN.1 variant dominance.

1 Mar 2024

Are your snacks deadly? New study reveals how ultra-processed foods lead to chronic disease outcomes

The association between ultra-processed food exposure and chronic disease outcomes.

1 Mar 2024

COVID-19's lasting mark: Long-term smell and taste loss

Study reveals prolonged olfactory and gustatory dysfunction in some COVID-19 recoverees, highlighting a need for better clinical support and understanding of long-term effects.

29 Feb 2024

Early exposure to air pollution tied to higher childhood asthma risk, disparities worsen impact

Study links early-life exposure to air pollution with increased childhood asthma risk, emphasizing stronger effects in socio-economically disadvantaged and Black children due to individual and community factors.

29 Feb 2024

U.S. flu vaccines expected to shift from quadrivalent to trivalent, researcher says

U.S. flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says a University of Michigan researcher.

29 Feb 2024

Deep learning-based model development to predict critical pediatric events in general wards

A model that predicts critical events in pediatric individuals admitted to the general ward.

29 Feb 2024

Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality

Researchers evaluated coronavirus disease 2019 (COVID-19)-related mortality among perimenopausal women.

29 Feb 2024

AI-based technology unlocks secrets of myasthenic-congenital syndromes

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

28 Feb 2024

Breakthrough blood test developed for early detection of sarcoidosis

A research project led by Lobelia Samavati, M.D., professor of internal medicine and molecular medicine and genetics at the Wayne State University School of Medicine, and supported by the National Institutes of Health (NIH), has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs.

28 Feb 2024

AI-based model enhances efficiency of Type II diabetes prevention efforts

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year -; nearly a third of all health care spending -; on treating preventable diseases like diabetes.

28 Feb 2024

Caffeine's protective effects against obesity and joint diseases supported by genetic study

The effects of caffeine levels in circulation by considering genetically predicted variations in caffeine metabolism.

28 Feb 2024

Sinusitis tied to elevated rheumatic disease risk

The common inflammatory condition sinusitis is linked to a 40% heightened risk of a subsequent diagnosis of rheumatic disease, particularly in the 5 to 10 years preceding the start of symptoms, finds research published in the open access journal RMD Open.

27 Feb 2024

Previous
1
...
4
5
6
7
8
9
10
...
1193
Next

Respiratory News and Research

Rapid molecular testing transforms treatment for community-acquired pneumonia

COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals

Can postbiotics improve athletic performance and recovery?

COVID-19 exposes deep-rooted structural inequities affecting vaccine uptake among ACB groups

CUNY and Pfizer launch new project to track acute respiratory infections across the United States

COVID-19 linked to long-lasting cognitive deficits, study finds

How long do cognitive and memory dysfunctions persist after SARS-CoV-2 infection?

Only 9% of older Americans vaccinated against RSV, study finds

Latest COVID-19 booster halves risk of moderate or severe disease in adults

Are your snacks deadly? New study reveals how ultra-processed foods lead to chronic disease outcomes

COVID-19's lasting mark: Long-term smell and taste loss

Early exposure to air pollution tied to higher childhood asthma risk, disparities worsen impact

U.S. flu vaccines expected to shift from quadrivalent to trivalent, researcher says

Deep learning-based model development to predict critical pediatric events in general wards

Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality

AI-based technology unlocks secrets of myasthenic-congenital syndromes

Breakthrough blood test developed for early detection of sarcoidosis

AI-based model enhances efficiency of Type II diabetes prevention efforts

Caffeine's protective effects against obesity and joint diseases supported by genetic study

Sinusitis tied to elevated rheumatic disease risk

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News